Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes.

Blood advances - 8 Oct 2024

Nead Kevin T, Kim Taebeom, Joo LiJin, McDowell Tina L, Wong Justin W, Chan Irenaeus C C, Brock Elizabeth, Zhao Jing, Xu Ting, Tang Chad, Lee Chang-Lung, Abe Jun-Ichi, Bolton Kelly L, Liao Zhongxing, Scheet Paul A, Lin Steven H

Abstract excerpt

ABSTRACT: Exposure to cancer therapies is associated with an increased risk of clonal hematopoiesis (CH). The objective of our study was to investigate the genesis and evolution of CH after cancer therapy. In this prospective study, we undertook error-corrected duplex DNA sequencing in blood samples collected before and at 2 time points after chemoradiation in patients with esophageal or lung cancer recruited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Clonal Hematopoiesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to ASXL1 gene

Share to DNMT3A gene

Share to Lung Neoplasms

Share to Mutation

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 38830141
DOI: 10.1182/bloodadvances.2024012929
PMCID: PMC11530395

Genes

TP53
ASXL1
DNMT3A
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes.PMID 38830141Read ↗

Cancer therapy shapes the fitness landscape of clonal hematopoiesis.Semantic proximity Read ↗

Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.Semantic proximity Read ↗

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.Semantic proximity Read ↗

Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.Semantic proximity Read ↗

Oncologic therapy shapes the fitness landscape of clonal hematopoiesisSemantic proximity Read ↗

Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.Semantic proximity Read ↗

The crossroads of cancer therapies and clonal hematopoiesis.Semantic proximity Read ↗

Age-related clonal hematopoiesis associated with adverse outcomes.Semantic proximity Read ↗

Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesisSemantic proximity Read ↗

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.Semantic proximity Read ↗

Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients.Semantic proximity Read ↗

Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.